A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies

Statistics in Medicine

Volumn 32, Issue 16, 2013, Pages 2767-2789

  Doros, Gheorghe ^a,b,c   Pencina, Michael ^a,b   Rybin, Denis ^a   Meisner, Allison ^a   Fava, Maurizio ^d  

^a BOSTON UNIVERSITY   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Placebo effect; Repeated measures; SPCD

Indexed keywords

PLACEBO;

ANALYTICAL ERROR; ARTICLE; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONTINUOUS OUTCOMES; DATA ANALYSIS; HYPOTHESIS; INTERMETHOD COMPARISON; LINEAR SYSTEM; OUTCOME ASSESSMENT; PARALLEL DESIGN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SEQUENTIAL PARALLEL COMPARISON DESIGN; SIMULATION; STATISTICAL MODEL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; COMPUTER SIMULATION; DEPRESSIVE DISORDER, MAJOR; HUMANS; LINEAR MODELS; PIPERAZINES; PLACEBO EFFECT; QUINOLONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84879131864     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5728     Document Type: Article

References (19)

1. Fava M, Evins AE, Dorer DJ, Schoenfeld DA. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychotherapy and Psychosomatics 2003; 72:115-127.
2. Trivedi MH, Rush J. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacology 1994; 11(1):33-43.
3. Walsh TB, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression. JAMA: The Journal of the American Medical Association 2002; 287(14):1840-1847.
4. Fava M, Schoenfeld D. System and method for reducing the placebo effect in controlled clinical trials. 2010. Available at: http://www.patentlens.net/patentlens/patent/US_7840419/en/ [Accessed on 20 July 2012].
5. Fava M, Schoenfeld D. System and method for reducing the placebo effect in controlled clinical trials. 2010. Available from: http://www.patentlens.net/patentlens/patent/US_7647235/en/ [Accessed on 20 July 2012].
6. Fava M, Schoenfeld D. System and method for reducing the placebo effect in controlled clinical trials. 2011. Available from: http://www.patentlens.net/patentlens/patent/US_7983936/en/ [Accessed on 20 July 2012].
7. Fava M, Schoenfeld D. System and method for reducing the placebo effect in controlled clinical trials. 2012. Available from: http://www.patentlens.net/patentlens/patent/US_8145504/en/ [Accessed on 20 July 2012].
8. Fava M, Schoenfeld D. System and method for reducing the placebo effect in controlled clinical trials. 2012. Available from: http://www.patentlens.net/patentlens/patent/US_8145505/en/ [Accessed on 20 July 2012].
9. Chen YF, Yang Y, Hung HJ, Wang SJ. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials. Contemporary Clinical Trials 2011; 32:592-604.
10. Huang X, Tamura RN. Comparison of test statistics for the sequential parallel design. Statistics in Biopharmaceutical Research 2010; 2:42-50.
11. Ivanova A, Qaqish B, Schoenfeld DA. Optimality, sample size, and power calculations for the sequential parallel comparison design. Statistics in Medicine 2011; 30(23):2793-2803.
12. Tamura RN, Huang X, Boos DD. Estimation of treatment effect for the sequential parallel design. Statistics in Medicine 2011; 30:3496-3506.
13. Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy (ADT) among depressed outpatients with inadequate response to prior ADT (ADAPT-A Study). The 48th Annual Meeting of the American College of Neuropsychopharmacology, 2009.
14. Tamura RN, Huang X. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials. Clinical Trials 2007; 4:309-317.
15. (U.S.) NRC. The Prevention and Treatment of Missing Data in Clinical Trials. National Academies Press: Washington, D.C., 2010.
16. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford University Press: Oxford, USA, 2002.
17. Daniels MJ, Hogan JW. Missing Data in Longitudinal Studies. Chapman & Hall/CRC Monographs on Statistics & Applied Probability: New York, 2008.
18. Hogan JW, Roy J, Korkontzelou C. Handling drop-out in longitudinal studies. Statistics in Medicine 2004; 23(9):1455-1497. Available from: http://dx.doi.org/10.1002/sim.1728 [Accessed on 20 July 2012].
19. Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (adapt-a study). Psychotherapy and Psychosomatics 2012; 81:87-97.